74 related articles for article (PubMed ID: 19841316)
1. How should we prevent hematologic relapse of acute promyelocytic leukemia?
Nagai S; Takahashi T; Kurokawa M
J Clin Oncol; 2010 Feb; 28(4):e62; author reply e63-4. PubMed ID: 19841316
[No Abstract] [Full Text] [Related]
2. The presence of a single PML-RARA isoform lacking exon 5 in FISH-negative APL samples.
Ashur-Fabian O; Trakhtenbrot L; Dominissini D; Koren-Michowitz M; Nagler A; Rechavi G; Amariglio N
Leukemia; 2008 Jan; 22(1):200-3. PubMed ID: 17960172
[No Abstract] [Full Text] [Related]
3. Treatment concepts of acute promyelocytic leukemia.
Lengfelder E; Saussele S; Weisser A; Büchner T; Hehlmann R
Crit Rev Oncol Hematol; 2005 Nov; 56(2):261-74. PubMed ID: 16236522
[TBL] [Abstract][Full Text] [Related]
4. An acute promyelocytic leukaemia patient with a new atypical promyelocytic leukemia breakpoint.
Cenfra N; De Cave F; Minotti C; Ghia E; Rago A; Codacci Pisanelli G; Diverio D; Cimino G
Br J Haematol; 2008 Sep; 142(5):854-6. PubMed ID: 18573113
[No Abstract] [Full Text] [Related]
5. Monitoring of minimal residual disease in acute promyelocytic leukemia.
Lengfelder E; Reiter A; Saussele S; Weisser A; Hehlmann R
Ann Hematol; 2004; 83 Suppl 1():S79-80. PubMed ID: 15124684
[No Abstract] [Full Text] [Related]
6. Epidermal growth factor in acute promyelocytic leukemia treated with retinoic acid.
Wu X; Qureshi IA; Liu H; Yin J; Qian X; Ruijie X
Int J Hematol; 1995 Aug; 62(2):83-9. PubMed ID: 8590777
[TBL] [Abstract][Full Text] [Related]
7. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
[TBL] [Abstract][Full Text] [Related]
8. Role of autologous bone marrow transplantation as consolidation therapy in acute promyelocytic leukemia patients in complete remission.
Ottaviani E; Martinelli G; Testoni N; Visani G; Tani M; Tura S
Haematologica; 1998 Nov; 83(11):1051-5. PubMed ID: 9864933
[TBL] [Abstract][Full Text] [Related]
9. Morphologic heterogeneity of acute promyelocytic leukemia: therapy-related acute promyelocytic leukemia presenting with FAB-M2 morphology.
Sinha S; Aish L; Oo TH
Am J Hematol; 2006 Jun; 81(6):475-6. PubMed ID: 16680741
[No Abstract] [Full Text] [Related]
10. Central nervous system relapse occurs in about 5% of cases of acute promyelocytic leukaemia.
Castagnola C; Elena C; Merli M
Haematologica; 2008 Feb; 93(2):e28. PubMed ID: 18245644
[TBL] [Abstract][Full Text] [Related]
11. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
Gameiro P; Vieira S; Carrara P; Silva AL; Diamond J; Botelho de Sousa A; Mehta AB; Prentice HG; Guimarães JE; Hoffbrand AV; Foroni L; Parreira A
Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
[TBL] [Abstract][Full Text] [Related]
12. Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy.
Breccia M; Diverio D; Noguera NI; Visani G; Santoro A; Locatelli F; Damiani D; Marmont F; Vignetti M; Petti MC; Lo Coco F
Haematologica; 2004 Jan; 89(1):29-33. PubMed ID: 14754603
[TBL] [Abstract][Full Text] [Related]
13. RT-PCR in diagnosis and disease monitoring of acute promyelocytic leukemia (APL).
Grimwade D; Langabeer S; Howe K; Solomon E
Methods Mol Biol; 1998; 89():333-58. PubMed ID: 9664338
[No Abstract] [Full Text] [Related]
14. Cryptic insertion (15;17) in a case of acute promyelocytic leukemia detected by fluorescence in situ hybridization.
Gutiérrez NC; García JL; Chillón C; Muntión S; González M; Hernández JM
Haematologica; 1999 Jan; 84(1):88-90. PubMed ID: 10091399
[No Abstract] [Full Text] [Related]
15. Quantitation of minimal residual disease in acute myeloid leukemia by tryptase monitoring identifies a group of patients with a high risk of relapse.
Sperr WR; Mitterbauer M; Mitterbauer G; Kundi M; Jäger U; Lechner K; Valent P
Clin Cancer Res; 2005 Sep; 11(18):6536-43. PubMed ID: 16166430
[TBL] [Abstract][Full Text] [Related]
16. Acute promyelocytic leukaemia with cryptic PML-RARA fusion.
Wong KF; Chow E; Siu LL; Wong WS
Br J Haematol; 2009 Apr; 145(1):2. PubMed ID: 19036120
[No Abstract] [Full Text] [Related]
17. When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group).
Cassinat B; de Botton S; Kelaidi C; Ades L; Zassadowski F; Guillemot I; Schlageter MH; Raffoux E; Harousseau JL; Legrand O; Escoffre-Barbe M; Reman O; Gardembas M; Himberlin C; Cahn JY; Guyotat D; Bouscary D; Parry A; Rousselot P; Baruchel A; Dombret H; Chevret S; Fenaux P; Chomienne C
Leuk Res; 2009 Sep; 33(9):1178-82. PubMed ID: 19167754
[TBL] [Abstract][Full Text] [Related]
18. The seventh pathogenic fusion gene FIP1L1-RARA was isolated from a t(4;17)-positive acute promyelocytic leukemia.
Kondo T; Mori A; Darmanin S; Hashino S; Tanaka J; Asaka M
Haematologica; 2008 Sep; 93(9):1414-6. PubMed ID: 18603554
[No Abstract] [Full Text] [Related]
19. The PML/RAR alpha fusion gene in the diagnosis and monitoring of acute promyelocytic leukemia.
Diverio D; Riccioni R; Mandelli F; Lo Coco F
Haematologica; 1995; 80(2):155-60. PubMed ID: 7628753
[TBL] [Abstract][Full Text] [Related]
20. Possible role of PML/RAR alpha fusion gene in leukaemogenesis.
Maeda Y; Horiuchi F; Sumimoto Y; Miyatake J; Matsuda M; Tatsumi Y; Irimajiri K; Horiuchi A
Br J Haematol; 1997 Apr; 97(1):245. PubMed ID: 9136977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
